🇺🇸 FDA
Patent

US 11299751

Compositions for the treatment of disease

granted A61KA61K35/76A61K38/00

Quick answer

US patent 11299751 (Compositions for the treatment of disease) held by VOYAGER THERAPEUTICS, INC. expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/76, A61K38/00, A61K9/0019